Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf”, “OILS”, or the “Company”), Canada’s most innovative cannabis extractor, is pleased to provide the following update:

Operations Update


Nextleaf is pleased with its operational progress as the oil refinery system has thus far performed consistently with the commissioning and scale up plan. To date, nearly 2 tonnes of biomass have been processed in the commissioning phase. Optimization has been consistent with planned timing. The current realized per shift capacity of turning cannabis biomass into refined oils is approximately 200kg. The Company’s Metro Vancouver extraction plant is well on its way to meet its design capacity. Given the current stage of optimization, Nextleaf is confident that by adding additional shifts it can process approximately 600kg per day.

“While scale is important as our industry grows domestically and internationally, much more important is the efficiency and margins that are derived from that scale, system and IP. We are quite pleased with the economics we’re seeing from our commission and optimization phase. We believe we are well positioned to be a focused, economical B2B supplier of bulk cannabinoids – now and in the future,” stated Charles Ackerman, Chief Financial Officer at Nextleaf.

Launch of Commercial Partners Program

The Company recently launched the OILS Commercial Partners Program as a focused solution for Canadian cannabis farmers requiring economical extraction and distillation services. Health Canada reported over 620 tonnes of unpackaged dried cannabis in inventories across the country as of April 30, 2020. With the largest cannabis harvest in history expected this fall, Nextleaf has designed this accretive program to make it easier for cultivators to monetize a greater percentage of their harvest. Under the program, licensed cultivators supply cannabis biomass to Nextleaf for processing into refined and distilled THC and CBD oils. Nextleaf will monetize the bulk oils through downstream manufacturing partners as well as supply the broader wholesale market. Proceeds of the program will be shared between Nextleaf and the cultivator.

Agreements with Wholesale Marketplace

With strategic geographical planning, Nextleaf has entered into three Cannabis Brokerage Agreements (the “Agreement“) covering the country from coast to coast. This tactical approach helps ensure broad national coverage beyond Nextleaf’s existing commercial clients.

“With the cannabis industry moving away from the vertical integration model and to a more focused and naturally delineated supply chain, we believe the wholesale B2B marketplace plays an important role. This is an efficient way for Nextleaf to wholesale cannabis oils to companies licensed to manufacture cannabis 2.0 products and create new potential partner relationships,” stated Charles Ackerman, Chief Financial Officer at Nextleaf.

Patent Issued in South Africa

The Company has been granted a patent in South Africa pertaining to OILS industrial-scale process of extraction, refinement, and distillation of cannabinoids. South Africa has an established and well-regarded pharmaceutical industry and the government will decide on the legalization of cannabis next month. This patent perpetuates the precedent set by the United States Patent and Trademark Office validating Nextleaf’s industrial-scale extraction and post-extraction processing technology.

The Company’s patented technology allows for dried cannabis and hemp biomass to be efficiently processed at scale into a high-purity THC and CBD distilled oil. Management believes that as cannabis continues to commoditize, proprietary technology, which allows companies to establish a low-cost competitive advantage, will become a focal point of differentiation and a key driver of long-term value.

As the global cannabis market continues to scale, Nextleaf’s internationally validated patent portfolio will create opportunities over the 20-year life of its patents. The Company will pursue international growth through alternatives based on the most accretive and resource efficient methods: intellectual property licensing, joint ventures, or proprietary cannabis oil refineries.

Corporate Outlook and Further Updates

With the optimization of Nextleaf’s refinery largely complete, the facility is fully commercialized and focused on fulfilling existing orders as well as finalizing larger opportunities enabled by its economies of scale – with the sole objective of obtaining profitability for ongoing operations of the Company’s oil refinery.

With Nextleaf’s fiscal year end on September 30, 2020, the Company will provide a robust corporate update and further operational progress towards the end of that month. The company will continue to provide guidance on its ongoing IP, commercial, and corporate milestones.

About Nextleaf®

OILS is Canada’s most innovative cannabis extractor, developing technology for extracting and distilling cannabinoids. OILS provides extraction services and wholesale of THC and CBD oils through its wholly owned subsidiary Nextleaf Labs Ltd., a Health Canada licensed standard processor. Nextleaf’s proprietary closed-loop extraction plant in Metro Vancouver has a design capacity to process 600 kg per day of dried cannabis biomass into distilled oils. OILS is the first public company to be issued U.S. patents for industrial-scale extraction and distillation of cannabinoids. The Company owns a portfolio of over 40 issued patents and 60 pending patents for the extraction, purification, and formulation of cannabinoids.

Nextleaf Solutions trades as OILS on the Canadian Securities Exchange, OILFF on the OTCQB Market in the United States, and L0MA on the Frankfurt Stock Exchange.

Follow OILS across social media platforms: Twitter, LinkedIn, Facebook, and Instagram.

www.nextleafsolutions.com

For commercial inquiries, please contact:
604-283-2301 (ext. 420)
sales@nextleafsolutions.com

For investor relations, please contact:
604-283-2301 (ext. 219)
investors@nextleafsolutions.com

On behalf of the Board of Directors of OILS,

Paul Pedersen, CEO

Certain statements contained in this press release constitute “forward-looking statements”. All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company’s ability to capitalize on its IP portfolio, the Company’s strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company’s MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The CSE has not reviewed, approved or disapproved the contents of this press release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/62183

copyright (c) newsfile corp. 2020

News Provided by Newsfile via QuoteMedia

In the evolving rush of mergers and acquisitions (M&A) in the Canadian cannabis market, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced it will acquire The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) in a deal worth approximately C$435 million.

Meanwhile, a cannabis operator in the US confirmed this week that it will receive a financial boost from a partner to solidify its position in the burgeoning Pennsylvania state market.

Keep reading... Show less

The Board of Directors of Aphria Unanimously Recommends Shareholders Vote “For” the Arrangement

Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination

Keep reading... Show less

Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), one of the UK’s leading CBD and Hemp product suppliers, announces that as part of the equity fundraise announced yesterday, Antony Calamita and Andrew Male, Directors of the Company, subscribed for 285,714 Ordinary Shares and 1,428,571 Ordinary Shares respectively. The subscriptions are at a price of 3.5 pence per ordinary share for a total of £60,000. Following these subscriptions, Antony Calamita is now interested in 54,385,714 Ordinary Shares, representing 8.61% of the Company’s share capital as increased by the fundraising, and Andrew Male is now interested in 6,138,196 Ordinary Shares, representing 0.97% of the Company’s issued share capital as increased by the fundraising

Further, the timetable for receipt of applications under the Broker Option, which was also announced yesterday, has been extended until 5:00 pm 9 April 2021 to capture additional interest which was unable to be completed yesterday.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to provide the following dial-in information for the Company’s upcoming Annual and Special Meeting (the “Meeting”) scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021. Shareholders and proxyholders may access the Meeting via teleconference by dialing 647-723-3984 or 1-866-365-4406 from Canada or the United States, then entering participation code “8487744” followed by the pound (“#”) sign.

In consideration of the COVID-19 pandemic and the recent restrictions imposed by the Ontario Provincial Government, shareholders and proxyholders will only be able to attend the Meeting via teleconference and will not be permitted to attend the Meeting in person at the address provided on the Notice of Annual and Special Meeting of Shareholders.

Keep reading... Show less

Gage Growth Corp. (“Gage” or the “Company”) (CSE:GAGE), a leading high-quality craft cannabis brand and operator in Michigan, announced today that it has signed an agreement with Blue River™ Extracts & Terpenes (“Blue River™”) to bring the brand’s award-winning solventless technology and other trademark branded products to the state’s medical patients and cannabis consumers. The Company will have exclusive rights to Blue River™’s premium product offerings in Michigan.

Keep reading... Show less